FDA Inspection 783891 — AcuLux, Inc.

AcuLux, Inc. — FEI 3002907759

The FDA completed an inspection of AcuLux, Inc. on May 30, 2012 in Naples, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 30, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Naples, FL (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures
334621 CFR 820.200(b)Analyzing service report
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.